Results 141 to 150 of about 87,208 (292)
This study identified six clinically relevant quality indicators feasible to measure using NSW population‐based data. However, these indicators were restricted to surgical processes and outcomes. A large gap remains in available data to produce reliable and clinically meaningful quality measurements across the entire patient pathway.
Candice Donnelly +7 more
wiley +1 more source
A Retrospective Real-World Study: The Efficacy and Safety of Immune Checkpoint Inhibitors Combined with Chemoradiotherapy in Limited-Stage Small Cell Lung Cancer. [PDF]
Cai R +5 more
europepmc +1 more source
The study identified key barriers to optimal patient‐centered care, including delayed diagnosis due to awareness and stigma‐related barriers among patients and caregivers, and opportunities to enhance multidisciplinary coordination. Resource limitations impacted nursing and psychosocial support, while access to support care varied across regions.
Edwin Pun Hui +10 more
wiley +1 more source
Postoperative swallowing recovery in oral and oropharyngeal cancer: A prospective analysis of functional changes and adjuvant therapy effects. [PDF]
Nguyen LTH, Vo DT, Thai TT, Ly XQ.
europepmc +1 more source
In advanced rectal cancer patients receiving total neoadjuvant therapy (TNT), overall tumor response did not differ by diabetes status or metformin use. However, among diabetic patients, metformin use was associated with higher overall complete response rates. These findings suggest a potential benefit of metformin in enhancing TNT response in diabetic
Sergei Bedrikovetski +7 more
wiley +1 more source
Nivolumab with definitive chemoradiotherapy for oesophageal squamous cell carcinoma (NOBEL): a multicentre, single-arm, phase 2 feasibility trial. [PDF]
Nomura M +14 more
europepmc +1 more source
Role of Postoperative Concurrent Chemoradiotherapy for Esophageal Carcinoma: A meta-analysis of 2165 Patients [PDF]
Jingjing Kang +5 more
openalex +1 more source

